Showing results (391-400 of 413) with videos related to

Sort By:
Pageof 42
Trends in Ecology & Evolution|October 24, 2020
Energy Flow Through Marine Ecosystems: Confronting Transfer EfficiencyTyler D Eddy, Joey R Bernhardt, Julia L Blanchard, et al.
The ISME Journal|January 31, 2015
A multitrophic model to quantify the effects of marine viruses on microbial food webs and ecosystem processesJoshua S Weitz, Charles A Stock, Steven W Wilhelm, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Potent small molecule CCR1 antagonistsJohn C Kath, William H Brissette, Matthew F Brown, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Benzimidazolone p38 inhibitorsMark A Dombroski, Michael A Letavic, Kim F McClure, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Evaluation and synthesis of polar aryl- and heteroaryl spiroazetidine-piperidine acetamides as ghrelin inverse agonistsSuvi T M Orr, Ramsay Beveridge, Samit K Bhattacharya, et al.
Molecular Psychiatry|August 8, 2012
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brainJ W Steele, S Ju, M L Lachenmayer, et al.
The Journal of Biological Chemistry|August 12, 2003
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseasesRonald P Gladue, Laurie A Tylaska, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptorDaniel W Kung, Steven B Coffey, Ryan M Jones, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical CandidateSamit K Bhattacharya, Kim Andrews, Ramsay Beveridge, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 InhibitorsJeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Pageof 42